MiNK Therapeutics, Inc. (INKT) Tops Q4 EPS by 44c
Tweet
Share
E-mailGet Alerts INKT Hot Sheet
Join SI Premium – FREE
MiNK Therapeutics, Inc. (NASDAQ: INKT) reported Q4 EPS of $0.23, $0.44 better than the analyst estimate of ($0.21).
For earnings history and earnings-related data on MiNK Therapeutics, Inc. (INKT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Ennis (EBF) Reports In-Line Q1 EPS
- Morgan Stanley Starts Adani Enterprises Ltd. (ADE:IN) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
